Abstract
We examined the expression levels of microRNAs (miRNAs (miRs)) in colorectal tumors (63 cancer specimens and 65 adenoma specimens) and paired non-tumorous tissues. Decreased expression of miR-143 and -145 was frequently observed in the adenomas and cancers tested, compared with miR-34a downregulation and miR-21 upregulation. Expression profiles of miR-143 and -145 were not associated with any clinical features. As the downregulation of miR-143 and -145 was observed even in the early phase of adenoma formation, the decreased expression of both miRs would appear to contribute mainly to the initiation step of tumorigenesis, not to the progression stage, and not to clinical prognostic factors. For clinical application, we changed the sequences of the passenger strand in the miR-143 duplex and performed chemical modification at the 3′-overhang portion of miR-143, leading to greater activity and stability to nuclease. The cell growth inhibitory effect of the chemically modified synthetic miR-143 in vitro was greater than that of endogenous miR-143. The miR-143 showed a significant tumor-suppressive effect on xenografted tumors of DLD-1 human colorectal cancer cells. These findings suggest that miR-143 and -145 are important onco-related genes for the initiation step of colorectal tumor development and that the chemically modified synthetic miR-143 may be a hopeful candidate as an RNA medicine for the treatment of colorectal tumors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kloosterman WP, Plasterk RH . The diverse functions of microRNAs in animal development and disease. Dev Cell 2006; 11: 441–450.
Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004; 101: 2999–3004.
Croce CM, Calin GA . miRNAs, cancer, and stem cell division. Cell 2005; 122: 6–7.
Gregory RI, Shiekhattar R . MicroRNA biogenesis and cancer. Cancer Res 2005; 65: 3509–3512.
Eder M, Scherr M . MicroRNA and lung cancer. N Engl J Med 2005; 352: 2446–2448.
McManus MT . MicroRNAs and cancer. Semin Cancer Biol 2003; 13: 253–258.
Akao Y, Nakagawa Y, Naoe T . MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. Oncol Rep 2006; 16: 845–850.
Akao Y, Nakagawa Y, Naoe T . MicroRNA-143 and -145 in colon cancer. DNA Cell Biol 2007; 26: 311–320.
Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N, Akao Y . Decreased expression of microRNAs-143 and -145 in human gastric cancers. Oncology 2009; 77: 12–21.
Akao Y, Nakagawa Y, Kitade Y, Kinoshita T, Naoe T . Down-regulation of micoRNAs-143 and -145 in B-cell malignancies. Cancer Sci 2007; 98: 1914–1920.
Akao Y, Nakagawa Y, Iio A, Naoe T . Role of microRNA-143 in Fas-mediated apoptosis in human leukemia Jurkat cells. Leuk Res 2009; 33: 1530–1538.
Behlke MA . Progress towards in vivo use of siRNAs. Mol Ther 2006; 13: 644–670.
Ueno Y, Inoue T, Yoshida M, Yoshikawa K, Shibata A, Kitamura Y et al. Synthesis of nuclease-resistant siRNAs possessing benzen-phosphate backbones in their 3′-overhang regions. Bioor Med Chem Lett 2008; 18: 5194–5196.
Ueno Y, Kato T, Sato K, Ito Y, Inoue T, Shibata A et al. Synthesis and properties of nucleic acid analogues consisting of a benzene-phosphate backbone. J Org Chem 2005; 70: 7925–7935.
Akao Y, Itoh T, Ohguchi K, Iinuma M, Nozawa Y . Interactive effects of polymethoxy flavones from Citrus on cell growth inhibition in human neuroblastoma SH-SY5Y cells. Bioorg Med Chem 2008; 16: 2803–2810.
Shin C . Cleavage of the star strand facilitates assembly of some microRNAs into Ago2-containing silencing complexes in mammals. Mol Cells 2008; 26: 308–313.
Lingel A, Simon B, Izaurralde E, Sattler M . Structure and nucleic-acid binding of the Drosophila Argonaute 2 PAZ domain. Nature 2003; 426: 465–469.
Yan KS, Yan S, Farooq A, Han A, Zeng L, Zhou MM . Structure and conserved RNA binding of the PAZ domain. Nature 2003; 426: 468–474.
Ma JB, Ye K, Patel DJ . Structural basis for overhang-specific small interfering RNA recognition by the PAZ domain. Nature 2004; 428: 318–322.
Michael MZ, O’ Connor SM, van Holst Pellekaan NG, Yang GP, James RJ . Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003; 1: 882–891.
Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M et al. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 2007; 72: 397–402.
Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008; 299: 425–436.
Esau C, Kang X, Peralta E, Hanson E, Marcusson EG, Ravichandran LV et al. MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 2004; 279: 52361–52365.
Chen X, Guo X, Zhang H, Xiang Y, Chen J, Yin Y et al. Role of miRNA-143 targeting KRAS in colorectal tumorigenesis. Oncogene 2009; 28: 1385–1392.
Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD . Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003; 115: 199–208.
Acknowledgements
We thank Dr Takagi, Dr Tanigawa (Osaka Medical College Hospital), Dr Takagi (Kyouritsu General Hospital), Dr Takahama, Dr Watanabe, Dr Iwata, Dr Kamiya, Dr Maruyama, Dr Shibata, Dr Kamano and Dr Ohkubo (Fujita Health University Hospital) for supplying samples. This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Akao, Y., Nakagawa, Y., Hirata, I. et al. Role of anti-oncomirs miR-143 and -145 in human colorectal tumors. Cancer Gene Ther 17, 398–408 (2010). https://doi.org/10.1038/cgt.2009.88
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cgt.2009.88
Keywords
This article is cited by
-
Epigenetics of colorectal cancer: biomarker and therapeutic potential
Nature Reviews Gastroenterology & Hepatology (2020)
-
PMAMCA: prediction of microRNA-disease association utilizing a matrix completion approach
BMC Systems Biology (2019)
-
Therapy resistance mediated by exosomes
Molecular Cancer (2019)
-
Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications
Cell Communication and Signaling (2019)
-
Cancer-associated fibroblasts enhance cell proliferation and metastasis of colorectal cancer SW480 cells by provoking long noncoding RNA UCA1
Journal of Cell Communication and Signaling (2019)